ANIP
Price
$58.46
Change
+$0.96 (+1.67%)
Updated
Jan 17 closing price
Capitalization
1.43B
40 days until earnings call
SGIOY
Price
$7.12
Change
+$0.10 (+1.42%)
Updated
Jan 17 closing price
Capitalization
12.4B
13 days until earnings call
Ad is loading...

ANIP vs SGIOY

Header iconANIP vs SGIOY Comparison
Open Charts ANIP vs SGIOYBanner chart's image
ANI Pharmaceuticals
Price$58.46
Change+$0.96 (+1.67%)
Volume$302.52K
Capitalization1.43B
Shionogi & Co
Price$7.12
Change+$0.10 (+1.42%)
Volume$194.34K
Capitalization12.4B
ANIP vs SGIOY Comparison Chart
Loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIP vs. SGIOY commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIP is a Hold and SGIOY is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (ANIP: $58.46 vs. SGIOY: $7.12)
Brand notoriety: ANIP and SGIOY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ANIP: 117% vs. SGIOY: 65%
Market capitalization -- ANIP: $1.43B vs. SGIOY: $12.4B
ANIP [@Pharmaceuticals: Other] is valued at $1.43B. SGIOY’s [@Pharmaceuticals: Other] market capitalization is $12.4B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIP’s FA Score shows that 0 FA rating(s) are green whileSGIOY’s FA Score has 2 green FA rating(s).

  • ANIP’s FA Score: 0 green, 5 red.
  • SGIOY’s FA Score: 2 green, 3 red.
According to our system of comparison, SGIOY is a better buy in the long-term than ANIP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIP’s TA Score shows that 3 TA indicator(s) are bullish while SGIOY’s TA Score has 6 bullish TA indicator(s).

  • ANIP’s TA Score: 3 bullish, 2 bearish.
  • SGIOY’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SGIOY is a better buy in the short-term than ANIP.

Price Growth

ANIP (@Pharmaceuticals: Other) experienced а +6.21% price change this week, while SGIOY (@Pharmaceuticals: Other) price change was +0.85% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.23%. For the same industry, the average monthly price growth was +2.88%, and the average quarterly price growth was -9.56%.

Reported Earning Dates

ANIP is expected to report earnings on May 08, 2025.

SGIOY is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.23% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGIOY($12.4B) has a higher market cap than ANIP($1.43B). ANIP has higher P/E ratio than SGIOY: ANIP (79.85) vs SGIOY (9.62). ANIP YTD gains are higher at: 5.753 vs. SGIOY (2.300). SGIOY has higher annual earnings (EBITDA): 242B vs. ANIP (107M). SGIOY has more cash in the bank: 563B vs. ANIP (221M). ANIP has less debt than SGIOY: ANIP (286M) vs SGIOY (9.41B). SGIOY has higher revenues than ANIP: SGIOY (427B) vs ANIP (487M).
ANIPSGIOYANIP / SGIOY
Capitalization1.43B12.4B12%
EBITDA107M242B0%
Gain YTD5.7532.300250%
P/E Ratio79.859.62830%
Revenue487M427B0%
Total Cash221M563B0%
Total Debt286M9.41B3%
FUNDAMENTALS RATINGS
ANIP vs SGIOY: Fundamental Ratings
ANIP
SGIOY
OUTLOOK RATING
1..100
714
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
902
PRICE GROWTH RATING
1..100
5555
P/E GROWTH RATING
1..100
9578
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SGIOY's Valuation (21) in the null industry is significantly better than the same rating for ANIP (89) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew significantly faster than ANIP’s over the last 12 months.

SGIOY's Profit vs Risk Rating (100) in the null industry is in the same range as ANIP (100) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew similarly to ANIP’s over the last 12 months.

SGIOY's SMR Rating (2) in the null industry is significantly better than the same rating for ANIP (90) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew significantly faster than ANIP’s over the last 12 months.

SGIOY's Price Growth Rating (55) in the null industry is in the same range as ANIP (55) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew similarly to ANIP’s over the last 12 months.

SGIOY's P/E Growth Rating (78) in the null industry is in the same range as ANIP (95) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew similarly to ANIP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIPSGIOY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
56%
Momentum
ODDS (%)
Bearish Trend 5 days ago
76%
Bullish Trend 5 days ago
65%
MACD
ODDS (%)
Bullish Trend 5 days ago
68%
Bullish Trend 5 days ago
57%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
73%
Bullish Trend 5 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
75%
Bearish Trend 5 days ago
70%
Advances
ODDS (%)
Bullish Trend 16 days ago
72%
Bullish Trend 6 days ago
64%
Declines
ODDS (%)
Bearish Trend 11 days ago
72%
Bearish Trend 19 days ago
62%
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
58%
Aroon
ODDS (%)
N/A
Bearish Trend 5 days ago
57%
View a ticker or compare two or three
Ad is loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

ANIP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with DRRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then DRRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIP
1D Price
Change %
ANIP100%
+1.67%
DRRX - ANIP
38%
Loosely correlated
+2.15%
PAHC - ANIP
30%
Poorly correlated
-0.53%
ORGO - ANIP
26%
Poorly correlated
+0.30%
PBH - ANIP
25%
Poorly correlated
+0.38%
AMRX - ANIP
24%
Poorly correlated
-0.60%
More

SGIOY and

Correlation & Price change

A.I.dvisor tells us that SGIOY and ANIP have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SGIOY and ANIP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGIOY
1D Price
Change %
SGIOY100%
+1.42%
ANIP - SGIOY
22%
Poorly correlated
+1.67%
EOLS - SGIOY
21%
Poorly correlated
-0.94%
TAK - SGIOY
20%
Poorly correlated
-1.00%
TKPHF - SGIOY
9%
Poorly correlated
N/A
ROMJF - SGIOY
8%
Poorly correlated
N/A
More